查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1405751

郁血性心臟衰竭治疗设备市场规模、份额、趋势分析报告：按产品、按地区、细分市场预测，2023-2030 年

Congestive Heart Failure Treatment Devices Market Size, Share & Trends Analysis Report By Product (Ventricular Assist Devices, Counter Pulsation Devices, Pacemakers), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10个工作天内

价格

郁血性心臟衰竭治疗设备市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球郁血性心臟衰竭器材市场规模将达到465.8亿美元，2023年至2030年复合年增长率为7.6%。

CVD负担的增加是导致该行业利润丰厚成长的主要因素之一。久坐的生活方式、精神压力和食用垃圾食物的倾向是心血管疾病发生的主要因素。

美国医疗保险制度等有利的报销政策被视为该行业的主要成长要素。该公司现在提供新产品平台，并提供有利于患者的折扣。报销适用于治疗 CHF 的设备，辅助人工心臟(VAD)、植入式心臟整流去颤器(ICD) 和心律调节器。

行业相关人员专注于开发能够提供个体化护理的高度实用的产品。这些进步提供了额外的功能来提高准确性、增强工作流程并降低错误率。

郁血性心臟衰竭治疗设备市场报告亮点

  • 市场依产品细分为辅助人工心臟、反搏装置、ICD、心律调节器和心臟再同步装置。 ICD领域包括经静脉和皮下两种类型，将在2022年占据有利的市场份额，其次是起搏器领域。这是因为心臟去颤器和心律调节器是心臟衰竭的第一线治疗方法。
  • 另一方面，由于保险报销范围和辅助人工心臟的技术进步，预计辅助人工心臟（VAD）领域在预测期内将出现强劲增长。
  • 辅助人工心臟依植入部位分为左心室辅助人工心臟（LVAD）及右心室辅助人工心臟（RVAD）。当 LVAD 和 RVAD 一起植入时，它们被称为双心室辅助装置 (BIVAD)。
  • 北美地区在整个市场中占据主导地位，2022 年收益占有率将超过 40.55%。这是由于受CVD影响的人口基数大以及老年人口基数大。
  • 市场参与企业正在积极努力改进其当前的产品系列，以保持其市场地位。此外，药物开拓和进入开拓国家的市场预计将推动市场成长。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章郁血性心臟衰竭治疗设备市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 郁血性心臟衰竭治疗设备市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章郁血性心臟衰竭治疗设备市场：产品评估与趋势分析

  • 郁血性心臟衰竭治疗设备市场：重点
  • 郁血性心臟衰竭治疗设备市场：2022 年和 2030 年产品变化和市场占有率分析
  • 郁血性心臟衰竭辅助装置（VAD）
  • 反搏装置
  • 植入式心臟整流去颤器
  • 起搏器
  • 心臟再同步治疗

第五章郁血性心臟衰竭设备市场：区域估计与趋势分析

  • 区域展望
  • 郁血性心臟衰竭治疗设备市场（按地区）：市场要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第六章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Jarvik Heart Inc.
    • ReliantHeart, Inc.
    • Biotronik SE & Co. KG
    • Berlin Heart GmbH
    • Abbott (St. Jude Medical)
    • Medtronic
    • Boston Scientific Corporation
    • Teleflex, Inc.
Product Code: GVR-1-68038-292-1

Congestive Heart Failure Treatment Devices Market Growth & Trends:

The global congestive heart failure treatment devices market size is expected to reach USD 46.58 billion by 2030, registering a CAGR of 7.6% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising burden of CVDs is one of the prime factors responsible for lucrative growth of this vertical. Sedentary lifestyles, mental stress, and junk food consumption tendencies are the key factors responsible for development of CVDs.

Favorable reimbursement policies, such as the U.S. Medicare system, are observed to be a prime growth factor for this industry. Companies now provide new product platforms, which have reimbursement coverage that benefit the patient. The reimbursement can be availed for devices, such as Ventricular Assist Devices (VADs), Implantable Cardiovascular Defibrillators (ICDs), and pacemakers, which are used to treat CHF.

The industry participants are more focused on developing high-utility products, which can deliver personalized care. These advancements are improving the accuracy and provide additional capabilities to enhance the workflow and reduce the incidence of errors.

Congestive Heart Failure Treatment Devices Market Report Highlights:

  • The market by product is segmented into VADs, Counter Pulsation Devices, ICDs, pacemakers, and cardiac resynchronization devices. The ICD segment consisting of two types, transvenous and subcutaneous, held a lucrative share in 2022, which was followed by the pacemaker's segment. This can be attributed to the fact that defibrillators and pacemakers form the primary line of treatment administered for heart failure.
  • On the other hand, the VAD segment is anticipated to grow at a significant rate over the forecast period due to reimbursement coverage and technological advancements in VADs.
  • The VAD based on the site of implantation are categorized into Left Ventricular Assist Devices (LVAD) and Right Ventricular Assist Devices (RVAD). When the LVAD and RVAD are implanted together they are termed Biventricular Assist Devices (BIVAD).
  • North America dominated the overall market in terms of revenue share at over 40.55% in 2022; this can be attributed to the presence of a large population base suffering from CVDs coupled with a significant geriatric population base.
  • The market participants are actively involved in the improvement of the current product portfolio, in order to sustain their market position. Additionally, drug development and their market entry in the untapped nations are expected to propel market growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. CHF Treatment Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. CHF Treatment Devices Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. CHF Treatment Devices Market: Product Estimates & Trend Analysis

  • 4.1. CHF Treatment Devices Market: Key Takeaways
  • 4.2. CHF Treatment Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Ventricular Assist Devices (VADs)
    • 4.3.1. Ventricular Assist Devices (VADs) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Counter Pulsation Devices
    • 4.4.1. Counter pulsation devices market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Implantable Cardioverter Defibrillators
    • 4.5.1. Implantable cardioverter defibrillators market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Pacemakers
    • 4.6.1. Pacemakers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Cardiac Resynchronization Therapy
    • 4.7.1. Cardiac resynchronization therapy market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. CHF Treatment Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. CHF Treatment Devices Market by Region: Key Marketplace Takeaways
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. UK
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Jarvik Heart Inc.
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. ReliantHeart, Inc.
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Biotronik SE & Co. KG
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. Berlin Heart GmbH
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. Abbott (St. Jude Medical)
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Medtronic
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Boston Scientific Corporation
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Teleflex, Inc.
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 France CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 18 China CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 India CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa CHF treatment devices market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE CHF treatment devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait CHF treatment devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 CHF treatment devices: market outlook
  • Fig. 9 CHF treatment devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 CHF treatment devices market driver impact
  • Fig. 15 CHF treatment devices market restraint impact
  • Fig. 16 CHF treatment devices market strategic initiatives analysis
  • Fig. 17 CHF treatment devices market: Product movement analysis
  • Fig. 18 CHF treatment devices market: Product outlook and key takeaways
  • Fig. 19 Ventricular Assist Devices (VADs) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 LVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 RVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 BiVAD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Counter Pulsation Devices market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Implantable Cardioverter Defibrillators market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Transvenous ICD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Subcutaneous ICD market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Implantable pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 External pacemakers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Cardiac Resynchronization therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Cardiac Resynchronization Therapy-Defibrillators (CRT-D) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cardiac Resynchronization Therapy-Pacemakers (CRT-P) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Global CHF treatment devices market: Regional movement analysis
  • Fig. 34 Global CHF treatment devices market: Regional outlook and key takeaways
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)